Sai Life Sciences Limited has issued a corrigendum to the notice of its 26th Annual General Meeting (AGM) to clarify details regarding the remuneration of Mr. Krishnam Raju Kanumuri, MD and CEO of the Company. The AGM is scheduled for September 11, 2025, and the corrigendum provides additional information on Items no. 4 and 5 of the Explanatory Statement to the AGM Notice.
The clarification pertains to the ‘Indicative PLI Parameters’ for Mr. Krishnam Raju Kanumuri. He will be eligible for a target PLI of between 3.25% to 3.5% of the net profits calculated as per audited financials for each financial year, i.e. profits after tax ('Target PLC') on 100% achievement of the defined performance parameters set by the NRC and the Board for that fiscal year.
The company has clarified that there is no change in the threshold percentages in relation to (1) the net profits (i.e. 3.25% to 3.5%) or (2) the fixed salary (upto 300%), which will continue to apply for the determination of the performance linked incentive.
Members are requested to consider the aforementioned points before casting their votes. The Corrigendum forms an integral part of the AGM Notice and should be read in conjunction with it. All other contents of the AGM Notice remain unchanged.
The Corrigendum is available on the company's website at www.sailife.com, and on the websites of the National Stock Exchange (NSE) at www.nseindia.com, the Bombay Stock Exchange (BSE) at www.bseindia.com, and the National Securities Depository Limited (NSDL) at www.evoting.nsdl.com.
Sai Life Sciences Limited (CIN: L24110TG1999PLC030970) is headquartered in Hyderabad, India.
Runa Karan
Company Secretary
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
